Edward D. Breen is the Executive Chairman and Chief Executive Officer of DuPont. Ed oversees the strategic direction of DuPont in creating value by unlocking the full potential of its distinctive capabilities, innovative portfolio, application expertise and deep customer relationships. Prior to his current role, Ed served as Executive Chairman and advanced the company’s strategy of active portfolio management, resulting in the separation of DuPont’s Nutrition & Biosciences business and subsequent merger with IFF. Before that, he was chief executive officer of DowDuPont. Prior to the DowDuPont merger, he was chairman and CEO of E.I. du Pont de Nemours and Company. Under his leadership, Ed has